Regulus Therapeutics (NASDAQ:RGLS) Sees Strong Trading Volume After Insider Buying Activity
Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) saw unusually-high trading volume on Thursday following insider buying activity. Approximately 1,111,494 shares were traded during mid-day trading, an increase of 22% from the previous session’s volume of 912,674 shares.The stock last traded at $7.99 and had previously closed at $7.95. Specifically, insider Preston Klassen acquired 12,000 […]
